Report - Dia 1 - NIV | Nederlands internisten vereniging Snapper 2017.pdf · 19-6-2017 6 Monoclonale antilichamen EGFR - Ras pathway Panitumumab Cetuximab BRAF remmers MEK inhibitors RAS mutatieEGFR

Please pass captcha verification before submit form